Gefitinib Completed Phase 1 Trials for Bioequivalence Study Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT03050164Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions